IL1B and Alzheimer disease: Reduced cognitive deficits in AD model mice; improved brain dendritic integrity and synaptic protein expression levels; inhibited microglia activation and reduced pro-inflammatory cytokines (IL-1β); reduced β-amyloid (Aβ) plaques in the hippocampus.